Ibis' Q4 results will be in line with previous guidance
Semiconductor Business News
DANVERS, Mass. -- Ibis Technology Corp., a supplier of silicon-on-insulator (SOI) implantation equipment, today announced that its fourth-quarter results will be in line with its previous guidance.
The company's sales are expected to range from $1.4-to-$1.6 million for the fourth quarter ended Dec. 31, compared to $1.4 million in the third quarter of 2001.
Net loss per share is expected to be between $0.40-to-$0.44 in the quarter, compared to a net deficit of $0.29 per share in the previous period. The previous quarter included a one-time other income item of $1.4 million, or $0.17 per share.
Earlier this month, Ibis announced it has successfully implanted 200- and 300-mm silicon wafers using its next-generation oxygen implanter, called the Ibis 2000. The tool had been developed for production of SOI wafers, based on separation by implantationtechnology, known as SIMOX (see Jan. 3 story ). |
